Update on Zika Diagnostic Tests and WHO’s Related Activities

PLoS Neglected Tropical Diseases

Volumn 11, Issue 2, 2017, Pages

  Chua, Arlene ^a,b   Prat, Irena ^a   Nuebling, Claudius Micha ^a   Wood, David ^a   Moussy, Francis ^a,c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; VIRAL PROTEIN; VIRUS RNA; YELLOW FEVER VACCINE; VIRUS ANTIBODY;

ALGORITHM; ARTICLE; CROSS REACTION; DENGUE VIRUS; DIAGNOSTIC TEST; EBOLAVIRUS; FLAVIVIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR DIAGNOSIS; PLAQUE REDUCTION NEUTRALIZATION TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TARGET PRODUCT PROFILE; VALIDATION PROCESS; VIREMIA; WORLD HEALTH ORGANIZATION; ZIKA FEVER; ZIKA VIRUS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; ETHICS; FEMALE; GENETICS; HEALTH CARE PLANNING; HEALTH CARE POLICY; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PROCEDURES; REPRODUCIBILITY; STANDARD; STANDARDS; VIROLOGY;

ANTIBODIES, VIRAL; DIAGNOSTIC TESTS, ROUTINE; DISEASE OUTBREAKS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH POLICY; HEALTH PRIORITIES; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; WORLD HEALTH ORGANIZATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85014537890     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005269     Document Type: Article

References (38)

1. World Health Organization(WHO). WHO Situation Report: Zika Virus Microcephaly Guillain-Barre Syndrome, December 2016. 2016.
2. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika Virus and Birth Defects—Reviewing the Evidence for Causality. 2016;: 1–7.
3. World Health Organization (WHO). WHO R&D Blueprint for action to prevent epidemics. http://www.who.int/csr/research-and-development/blueprint/en/.
4. World Health Organization. Target Product Profiles for better diagnostic tests for Zika Virus Infection. 2016; http://www.who.int/csr/research-and-development/zika-tpp.pdf?ua=1.
5. Duffy MR, Chen T-H, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med.2009; 360:2536–2543. doi: 10.1056/NEJMoa080571519516034
6. CDC. Zika Virus—What Clinicians Need to Know? Clinician Outreach and Communication Activity. 2016;
7. Besnard M, Lastère S, Teissier A, Cao-Lormeau VM, Musso D, Evidence of perinatal transmission of zika virus, French Polynesia, December 2013 and February 2014. Eurosurveillance2014; 19:8–11.
8. Zammarchi L, Stella G, Mantella A, et al. Zika virus infections imported to Italy: Clinical, immunological and virological findings, and public health implications. J. Clin. Virol.2015; 63:32–35. doi: 10.1016/j.jcv.2014.12.00525600600
9. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg. Infect. Dis.2008; 14:1232–1239. doi: 10.3201/eid1408.08028718680646
10. Gourinat AC, O???Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M, Detection of zika virus in urine. Emerg. Infect. Dis.2015; 21:84–86. doi: 10.3201/eid2101.14089425530324
11. Driggers RW, Ho C-Y, Korhonen EM, et al. Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities. N. Engl. J. Med.2016;: NEJMoa1601824.
12. Lustig Y, Mendelson E, Paran N, Melamed S, Schwartz E, Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016. Eurosurveillance2016; 21:1–4.
13. Bingham AM, Cone M, Mock V, Heberlein-larson L, Stanek D, Comparison of Test Results for Zika Virus RNA in Urine, Serum, and Saliva Specimens from Persons with Travel-Associated Zika Virus Disease—Florida, 2016. 2016; 65:475–478. doi: 10.15585/mmwr.mm6518e227171533
14. Zhang F-C, Li X-F, Deng Y-Q, Tong Y-G, Qin C-F, Excretion of infectious Zika virus in urine. Lancet Infect. Dis.2016; 3099:30070. http://linkinghub.elsevier.com/retrieve/pii/S1473309916300706.
15. Cao-Lormeau V, Blake A, Mons S, et al. Guillain-Barré Syndrome outbreak caused by ZIKA virus infection in French Polynesia. Lancet2016; 6736:In press.
16. Tappe D, Rissland J, Gabriel M, et al. First case of laboratory-confirmed zika virus infection imported into Europe, November 2013. Eurosurveillance2014; 19:1–4.
17. Sirohi D, Chen Z, Sun L, et al. The 3.8 Å resolution cryo-EM structure of Zika virus. Science2016; 352:467–70. http://www.ncbi.nlm.nih.gov/pubmed/27033547%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4845755.
18. Priyamvada L, Quicke KM, Hudson WH, et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl. Acad. Sci. U. S. A.2016; 113:7852–7. http://www.ncbi.nlm.nih.gov/pubmed/27354515\nhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4948328. doi: 10.1073/pnas.160793111327354515
19. Baden LR, Petersen LR, Jamieson DJ, Powers AM, Honein MA, Zika Virus. N. Engl. J. Med.2016;: NEJMra1602113.
20. Fornara C, Furione M, Lilleri D, et al. Primary human cytomegalovirus infections: Kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects. J. Clin. Virol.2015; 64:45–51. doi: 10.1016/j.jcv.2015.01.00425728078
21. Ramdasi AY, Arya RP, Arankalle VA, Effect of pregnancy on anti-HEV antibody titres, plasma cytokines and the corresponding gene expression levels in the PBMCs of patients presenting with self-recovering clinical and subclinical hepatitis E. PLoS ONE2014; 9.
22. Gotuzzo E, Yactayo S, Córdova E, Review article: Efficacy and duration of immunity after yellow fever vaccination: Systematic review on the need for a booster every 10 years. Am. J. Trop. Med. Hyg.2013; 89:434–444.
23. Sarno M, Sacramento GA, Khouri R, et al. Zika Virus Infection and Stillbirths: A Case of Hydrops Fetalis, Hydranencephaly and Fetal Demise. PLoS Negl Trop Dis2016; 10:e0004517. http://dx.plos.org/10.1371/journal.pntd.0004517. doi: 10.1371/journal.pntd.000451726914330
24. Mlakar J, Korva M, Tul N, et al. Zika Virus Associated with Microcephaly. N. Engl. J. Med.2016;: 160210140106006.
25. Calvet G, Aguiar RS, Melo ASO, et al. Detection and sequencing of Zika virus from amniotic fl uid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis2016; 3099:1–8.
26. Martines RB, Bhatnagar J, Keating MK, et al. Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses—Brazil, 2015. MMWR, Morb. Mortal. Wkly. Rep. 2016; 65:2015–2016.
27. ECDC. Rapid Risk Assessment. Zika virus disease epidemic: potential association with microcephaly and Guillain-Barré syndrome. First update—21 January 2016. 2016;: 1–20.
28. Adibi JJ, Marques ETA, Cartus A, Beigi RH, Teratogenic effects of the Zika virus and the role of the placenta. Lancet2016; 6736:1–4. http://linkinghub.elsevier.com/retrieve/pii/S0140673616006504.
29. Chen Z, Zhu H, A Rapid, Self-confirming Assay for HIV: Simultaneous Detection of Anti- HIV Antibodies and Viral RNA. J. AIDS Clin. Res.2016; 7:1–8. http://www.omicsonline.org/open-access/a-rapid-selfconfirming-assay-for-hiv-simultaneous-detection-of-antihiv-antibodies-and-viral-rna-2155-6113-1000540.php?aid=67649.
30. World Health Organization. Meeting Report: High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting. 2014;
31. Porrás AI, Yadon ZE, Altcheh J, et al. Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment. PLoS Negl Trop Dis2015; 9:e0003697. http://dx.plos.org/10.1371/journal.pntd.0003697. doi: 10.1371/journal.pntd.000369726042730
32. UNICEF. INNOVATIVE HIV POINT-OF-CARE (POC) CD4, EID AND VIRAL LOAD EQUIPMENT PROJECT Early Infant Diagnosis (EID) and Viral Load (VL) POC TECHNOLOGY 2015. 2015;
33. Chua AC, Cunningham J, Moussy F, Perkins MD, Formenty P, The Case for Improved Diagnostic Tools to Control Ebola Virus Disease in West Africa and How to Get There. PLoS Negl Trop Dis2015; 9:e0003734. http://dx.plos.org/10.1371/journal.pntd.0003734. doi: 10.1371/journal.pntd.000373426068890
34. Brasil P, Pereira JP, Jr.Raja Gabaglia C, et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro—Preliminary Report. N. Engl. J. Med.2016;: NEJMoa1602412.
35. World Health Organization (WHO). Zika Diagnostic tests Pipeline.
36. Corman VM, Rasche A, Baronti C, et al. Clinical comparison, standardization and optimization of Zika virus molecular detection. Bull. World Health Organ.2016; http://www.who.int/bulletin/online_first/16-175950.pdf.
37. Baylis SA, Hanschmann KO, Schnierle BS. Collaborative Study to Evaluate a Candidate World Health Organization International Standard for Zika Virus for Nucleic Acid Amplification. 2016. http://www.who.int/csr/research-and-development/zika/zika_virus_bs_2016_2286_2_july_2016.pdf?ua=1.
38. Trösemeier J, Musso D, Blümel J, Thézé J, Pybus OG, Baylis A, Genome Sequence of a Candidate World Health Organization Reference Strain of Zika Virus for Nucleic Acid Testing. 2016; 4:4–5.